This Collaborative Procedure has been developed based on the above-mentioned considerations to enhance timely access to WHO prequalified products in countries, to ensure “sameness” can be demonstrated, that the product in countries is the same as the one which is WHO prequalified and to provide a model for regulatory information exchange between countries.
